Cart
sales@molnova.com
LMPTP INHIBITOR 1 hydrochloride
CAS No. ——
LMPTP INHIBITOR 1 hydrochloride ( —— )
Catalog No. M19464 CAS No. ——
LMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 215 | Get Quote |
|
| 5MG | 331 | Get Quote |
|
| 10MG | 522 | Get Quote |
|
| 25MG | 731 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLMPTP INHIBITOR 1 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
DescriptionLMPTP INHIBITOR 1 is a selective inhibitor of low molecular weight protein tyrosine phosphatase (LMPTP) with an IC50 of 0.8 μM LMPTP-A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhosphatase
-
RecptorLMPTP-A
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight517.54
-
Molecular FormulaC28H38Cl2N4O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCl.Cl.CCN(CC)C(=O)c1ccc(cc1)-c1cc(NCCCN2CCCCC2)c2ccccc2n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stanford SM1 et al. Diabetes reversal by inhibition of the low-molecular-weight tyrosine phosphatase. Nat Chem Biol. 2017 Jun;13(6):624-632.
molnova catalog
related products
-
CDC25B-IN-1
CDC25B-IN-1 is an inhibitor of CDC25B with a Ki of 8.5 μM.
-
MLS000544460
MLS000544460 is a highly selective and reversible Eya2 phosphatase inhibitor (Kd: 2.0 μM, IC50: 4 μM) that exhibits inhibitory effects on Eya2 phosphatase-mediated cell migration and has anticancer activity.
-
h-NTPDase-IN-3
h-NTPDase-IN-3 is an h-NTPDase inhibitor that inhibits h-NTPDase1, h-NTPDase2, h-NTPDase3 and h-NTPDase8.
